Effect of Incentive Spirometery on Asthmatic Pregnant Women

Asthmatic Clinical Trial

Official title:

Effect of Incentive Spirometery on Asthmatic Pregnant Women

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05904002
• Other study ID #: Eman_Amin_2023
• Status: Completed
• Phase: N/A
• Start date: September 20, 2020
• Est. completion date: February 15, 2022

Study information

• Verified date: June 2023
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine the effect of the incentive spirometer on asthma during pregnancy.

Description:

This study will provide an evidence basis for obstetricians and physical therapist for women's health about the effect of spirometry on asthma during pregnancy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: February 15, 2022
• Est. primary completion date: September 15, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 30 Years to 40 Years

Eligibility

Inclusion Criteria:

The patients will have the following criteria:

1. Their age will range from 30 to40years old.

2. Body mass index (BMI) will range from 25-29.9 kg/m2.

3. All patients will be clinically and medically stable. Exclusion Criteria:

Patients will be excluded from the study if they have the following:

1. Diabetes mellitus.

2. Severe hypertension.

3. Neurological and neuromuscular disorders.

4. Blindness.

5. Developed moderate and severe degree of pleural effusion.

6. Cardiovascular instability.

7. Chronic chest disease.

Related Conditions & MeSH terms

• Asthma
• Asthmatic
• Pregnancy Complications
• Pregnant With Complication

Intervention

Drug:
• pulmicort inhaler
Each woman in both groups (A&B) will receive pulmicort inhaler on needs.

Device:
• Incentive spirometer treatment
Each patient in group B will be instructed about the effects of incentive spirometer to gain their cooperation during the study course.

Locations

Country	Name	City	State
Egypt	Outpatient clinic faculty of physical therapy cairo university	Dokki

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Assessing the change in lung functions	The spirometer will be used for assessment of lung functions including total lung capacity (TLC) (litre), which is the most widely used functional index in the asthma follow up.	at baseline and after 6 weeks of intervention
Primary	Assessing the change in symptoms of asthma	The Asthma Control Test provides a numerical score to help you and your healthcare provider determine if your asthma symptoms are well controlled. Take this test if you are 12 years or older. Share the score with your healthcare provider.	at baseline and after 6 weeks of intervention